Latest News

Date Title Topic
06 Dec 2016 PFS Significantly Longer With Osimertinib Than With Platinum-Pemetrexed in EGFR T790M-Positive Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
06 Dec 2016 Now available in Italian the ESMO/ACF Patient Guides on Bone and Soft Tissue Sarcoma
05 Dec 2016 Suicide in Survivors of Cancer in Childhood, Adolescence and Young Adulthood Cancer in Special Situations
25 Nov 2016 ESC Position Paper on Anticancer Treatments and Cardiovascular Toxicity Palliative and supportive care
24 Nov 2016 NICE Issues Evidence Based Recommendations on Nivolumab for Previously Treated Advanced RCC Genitourinary cancers - Cancer Immunology and Immunotherapy
23 Nov 2016 FDA Approves Daratumumab in Combination with Lenalidomide and Dexamethasone or Bortezomib and Dexamethasone for Multiple Myeloma Treatment Haematologic malignancies - Anticancer agents & Biologic therapy
23 Nov 2016 Media Alert: Catch Up on Cancer News at ESMO Asia 2016
21 Nov 2016 EMA Revises the Guideline on First-in-Human Clinical Trials Bioethics, legal and economic issues
16 Nov 2016 Direct Small-Molecule Inhibitors of KRAS Translational research
15 Nov 2016 EMA Recommends Extension of Therapeutic Indications for Ofatumumab Haematologic malignancies - Anticancer agents & Biologic therapy
14 Nov 2016 EMA Recommends Extension of Therapeutic Indications for Vandetanib Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
11 Nov 2016 FDA Approves Nivolumab for SCCHN Head and neck cancers - Cancer Immunology and Immunotherapy
09 Nov 2016 Pembrolizumab in Head & Neck Cancer Head and neck cancers
08 Nov 2016 How Big Data Can Be Used for the Development and Regulation of Medicines Translational research
08 Nov 2016 Media Alert: ESMO Asia 2016 – Cancer Experts Meet in Singapore from 16 to 19 December 2016